Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

prognostic factors

  • Open Access
    Exploring Demographic, Prognostic, and Socioeconomic Determinants of Survival in Lymphocyte-rich Classical Hodgkin Lymphoma: A National Cancer Database Study
    SUSAN RAFIE, BEAU HSIA, ARYN LAYNO, AMBER CHANG, PETER T. SILBERSTEIN and TIMOTHY BROWN
    Anticancer Research October 2025, 45 (10) 4343-4355; DOI: https://doi.org/10.21873/anticanres.17784
  • Open Access
    Impact of Radiation Dose on the Survival of Patients With Non-small Cell Lung Cancer Treated With Palliative Intent: Results of a Multicenter Prospective Study
    VERONICA CAÑÓN, JOSE LUIS LÓPEZ-GUERRA, ANDER ARTEAGOITIA, OLGA DEL HOYO, FERNAN SUAREZ, DAVID BÜCHSER, ALFONSO GÓMEZ-ITURRIAGA, ARTURO NAVARRO-MARTIN, ROBERTO ORTIZ DE ZARATE, JOSE FERNANDO PÉREZ AZORÍN, DIRK RADES and JON CACICEDO
    Anticancer Research December 2024, 44 (12) 5477-5484; DOI: https://doi.org/10.21873/anticanres.17373
  • Open Access
    Palliative Radiation Treatment in Patients Managed With Advanced/Interventional Pain Therapy such as Pump-delivered Continuous Opioids
    CARSTEN NIEDER, STINE M. JENSEN, SOLVEIG NILSEN and ELLINOR C. HAUKLAND
    Anticancer Research October 2024, 44 (10) 4419-4425; DOI: https://doi.org/10.21873/anticanres.17271
  • You have access
    Optimizing Therapeutic Approaches in Superficial Esophageal Cancer: Reduced-volume Radiotherapy and Dose-dense Chemotherapy After Endoscopic Resection
    GEN SUZUKI, HIDEYA YAMAZAKI, NORIHIRO AIBE, KOJI MASUI, TAKUYA KIMOTO, SHINSUKE NAGASAWA, KANAKO KAWABATA, TOMOHIRO KAJIKAWA, YUKI YOSHINO, SHO SERI, AKITO ASATO, OSAMU DOHI, TAKESHI ISHIKAWA, ETSUYO OGO, HANY ELSALEH and KEI YAMADA
    Anticancer Research July 2024, 44 (7) 3133-3139; DOI: https://doi.org/10.21873/anticanres.17127
  • You have access
    Complete Cycles of Radium-223 Improve Overall Survival in Patients With Metastatic Castration-resistant Prostate Cancer: A Retrospective Study
    HAN-CHUNG YANG, LI-WEN CHANG, JIAN-RI LI, SHIAN-SHIANG WANG, CHENG-KUANG YANG, CHUAN-SHU CHEN, KEVIN LU, CHENG-CHE CHEN, SHU-CHI WANG, CHIA-YEN LIN, CHEN-LI CHENG, YEN-CHUAN OU, KUN-YUAN CHIU and SHENG-CHUN HUNG
    Anticancer Research April 2023, 43 (4) 1809-1816; DOI: https://doi.org/10.21873/anticanres.16334
  • You have access
    The Prognostic Significance of p16 and its Role as a Surrogate Marker for Human Papilloma Virus in Oral Squamous Cell Carcinoma: An Analysis of 281 Cases
    CHRISTIAN DOLL, CLAUDIUS STEFFEN, BENEDICTA BECK-BROICHSITTER, MAXIMILIAN RICHTER, KONRAD NEUMANN, ANNE POHRT, PHILIPP LOHNEIS, ANNIKA LEHMANN, MAX HEILAND, CARMEN STROMBERGER, ANNEKATRIN COORDES, KORINNA JOHRENS and JAN-DIRK RAGUSE
    Anticancer Research May 2022, 42 (5) 2405-2413; DOI: https://doi.org/10.21873/anticanres.15719
  • You have access
    Clinical Significance of Chemokine Receptor CXCR4 and CCR7 mRNA Expression in Patients With Colorectal Cancer
    SHINSUKE NAGASAWA, KAZUHITO TSUCHIDA, MANABU SHIOZAWA, YUKIHIKO HIROSHIMA, YAYOI KIMURA, ITARU HASHIMOTO, HAYATO WATANABE, KAZUKI KANO, MASAKATSU NUMATA, TORU AOYAMA, SUMITO SATO, TAKANOBU YAMADA, HIROSHI TAMAGAWA, NAOTO YAMAMOTO, TAKASHI OGATA, SOICHIRO MORINAGA, NORIO YUKAWA, YASUSHI RINO, MUNETAKA MASUDA, HIROSHI SAEKI, YOHEI MIYAGI and TAKASHI OSHIMA
    Anticancer Research September 2021, 41 (9) 4489-4495; DOI: https://doi.org/10.21873/anticanres.15259
  • You have access
    Prognostic Factors for Advanced/Recurrent Breast Cancer Treated With Immune-cell Therapy
    RISHU TAKIMOTO, TAKASHI KAMIGAKI, SACHIKO OKADA, HIROSHI IBE, ERI OGUMA and SHIGENORI GOTO
    Anticancer Research August 2021, 41 (8) 4133-4141; DOI: https://doi.org/10.21873/anticanres.15216
  • You have access
    Palliative Local Radiotherapy for Advanced Squamous Cell Carcinoma of the Head-and-Neck: Prognostic Factors of Survival
    CHRISTIAN STAACKMANN, JULIKA RIBBAT-IDEL, SVEN PERNER, CHRISTIAN IDEL, KARL L. BRUCHHAGE, SAMER G. HAKIM, STEVEN E. SCHILD and DIRK RADES
    Anticancer Research June 2021, 41 (6) 3205-3210; DOI: https://doi.org/10.21873/anticanres.15107
  • You have access
    Baseline Tumour Size as a Prognostic Factor for Radioiodine-refractory Differentiated Thyroid Cancer Treated With Lenvatinib
    NAOKI FUKUDA, KAZUHISA TODA, AKIHIRO OHMOTO, XIAOFEI WANG, NAOMI HAYASHI, TETSUYA URASAKI, YASUYOSHI SATO, KENJI NAKANO, MAKIKO ONO, JUNICHI TOMOMATSU, HIROKI MITANI and SHUNJI TAKAHASHI
    Anticancer Research March 2021, 41 (3) 1683-1691; DOI: https://doi.org/10.21873/anticanres.14932

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire